FreshRecalls

⚠ Data freshness notice: the most recent refresh of NHTSA was incomplete, so a very recent recall may be missing. Everything shown is accurate as of the last checked time on this page — for anything time-critical, confirm with the official sources linked below.

FDAClass II · Drug · Recalled June 10, 2026

EQUALINE extra strength recall — Guardian Drug Co. Inc.

Hazard: Presence of foreign substance: small metallic particles in chewable tablets.

Class II: may cause temporary or medically reversible health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID
D-0576-2026
Brand
Guardian Drug Co
Classification
Class II
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Description

EQUALINE extra strength, antacid tablets, calcium carbonate 750mg, 96 chewable tablets, DISTRIBUTED BY SUPERVALU INC.,EDEN PRARIE, MN 55344 USA, NDC 41163-129-22.

Affected products

Companies & origin

Recalling firm location
Dayton, NJ, United States
Firm address
2 Charles Ct, 08810-1508

Identifying details (verbatim from the notice)

Product codes / lots
Lot #: 1276118, expires: JAN- 2029.
Distribution
U.S.A. Nationwide
Firm notified the public via
Letter
FDA event ID
99098
Recall initiated
May 28, 2026
FDA classified
June 3, 2026
FDA report date
June 10, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 23, 2026 at 11:04 PM UTC.

Report a data error on this page